Chengda biology Co., Ltd. focuses on the innovation and upgrading of traditional vaccines and the research and development of new products. In order to achieve the goal of annual output of 3-4 million injections, it needs to adopt highly automated equipment for production. The process of vaccine production using biotechnology is complex, and the equipment must meet the high stability and the highest cleanliness level. Benxi Branch's new workshop for hepatitis A vaccine and diploid rabies vaccine stock solution, Cfam-40 cell factory automation equipment of our company was used to complete the task of processing cell factory, creating the first application of such equipment in biotechnology vaccine production in China. The adoption of CFAM-40 cell factory automation equipment of our company has brought higher production efficiency, shortened the product launch time, and achieved the purpose of cost reduction, efficiency increase and compliant production.